Search - tctmd.com

Displaying 41 - 60 of 771

Sort: Relevancy | Date

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Michael O'Riordan

May 14, 2025

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Todd Neale

May 09, 2025

News Daily News

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

Yael L. Maxwell

April 25, 2025

News Daily News

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Todd Neale

April 23, 2025

News Daily News

Cardiotoxicity Rare With Common GI Chemotherapy

L.A. McKeown

April 15, 2025

News Daily News

Weekend Warriors Also See Mortality Benefits With Exercise

Michael O'Riordan

April 10, 2025

News Conference News EHRA 2025

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

Todd Neale

March 31, 2025

Presentation ACC 2025

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Presenter: Isabelle Mahé

March 29, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Years After Radiation Therapy, Echo Parameters Worse in Breast Cancer Patients

Caitlin E. Cox

March 11, 2025

Podcast TCTMD Talking Points

The PROACT Trial

March 05, 2025

News Daily News

Orthopedic and Radiation Injuries Unchanged in Cath Lab Staff Since 2014

L.A. McKeown

March 05, 2025

News Daily News

Survey Calls Out Implicit Bias in Peripheral Vascular Care

L.A. McKeown

February 28, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

Advertisement

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Obesity-Related Cancer Rates No Different With GLP-1s vs Bariatric Surgery

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Funding for Women’s Health Initiative Imperiled, but Appears Secure for Now

PFO, Risk Factors Both Exert Influence in Younger Cryptogenic Stroke Patients

Cardiotoxicity Rare With Common GI Chemotherapy

Weekend Warriors Also See Mortality Benefits With Exercise

Pulsed-Field Ablation Equals, and May Top, Cryoablation for Paroxysmal AF

Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

What’s Going to Be Hot at ACC 2025?

March 2025 Dispatch for the CV Team

Years After Radiation Therapy, Echo Parameters Worse in Breast Cancer Patients

The PROACT Trial

Orthopedic and Radiation Injuries Unchanged in Cath Lab Staff Since 2014

Survey Calls Out Implicit Bias in Peripheral Vascular Care

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

January 2025 Dispatch for the CV Team

Aspirin Use for Primary Prevention Declining in US: NHANES

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content